Corcept Therapeutics, Inc. (CORT) Misses Q1 Loss views by 2c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $122.25 +0.99%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
